Disclosure Panels Details Page

Acute Lymphoblastic Leukemia Panel - Disclosures as of 11/04/2013

Panel Member Clinical Research Support/Data Safety Monitoring Board Scientific Advisory Boards, Consultant, or Expert Witness Promotional Advisory Boards, Consultant, or Speakers Bureau Employment/ Governing Board, Patent, Equity, or Royalty for Panel Member or Dependent Spouse/Domestic Partner/Dependent Potential Conflict Has Attended
Joseph Alvarnas MD Bone Marrow Transplant Clinical Trials Network
National Cancer Institute
National Heart, Lung, and Blood Institute
Juno Evidence Based Oncology/American Journal of Managed Care
Med Learning Group
Plexus Communications
None None
Patricia Aoun MD, MPH None None None None NA
Karen Ballen MD None None None None None
Naresh Bellam MD, MPH None Celgene Corporation None None NA
William Blum MD AbbVie, Inc.
Agios, Inc.
Astellas Pharma US, Inc.
Boehringer Ingelheim GmbH
Celator, Inc
Celgene Corporation
Gilead
Karyopharm
Novartis Pharmaceuticals Corporation
Prism Pharma
Stemline
Novartis Pharmaceuticals Corporation Novartis Pharmaceuticals Corporation None None
Michael Boyer MD None Thunder Biotech None None NA
Patrick Brown MD None Amgen Inc.
Kite Pharma
Kura Oncology, Inc.
Novartis Pharmaceuticals Corporation
Takeda Pharmaceuticals North America, Inc.
None None NA
Hetty Carraway MD None None None None NA
Peter Coccia MD None None None None NA
Steven Coutre MD AbbVie, Inc.
Acerta Pharma
BeiGene
Janssen Pharmaceutica Products, LP
Pharmacyclics
AbbVie, Inc.
Adaptive
AstraZeneca Pharmaceuticals LP
Genentech, Inc.
Janssen Pharmaceutica Products, LP
Pharmacyclics
None None NA
Lloyd Damon MD Novartis Pharmaceuticals Corporation
Sigma-Tau Pharmaceuticals, Inc.
None None None None
Daniel DeAngelo MD, PhD Daiichi- Sankyo Co.
Fibrogen
Mt Sinai MPN Consortium
None Amgen Inc.
Blueprint Medicines
Jazz Pharmaceuticals Inc.
Kite Pharma
Novartis Pharmaceuticals Corporation
Pfizer Inc.
Servier
None NA
Dan Douer MD Amgen Inc.
Bristol-Myers Squibb Company
Gilead
Incyte
Sigma-Tau Pharmaceuticals, Inc.
Amgen Inc.
Gilead
Pfizer Inc.
Sigma-Tau Pharmaceuticals, Inc.
Spectrum
None None None
Haydar Frangoul MD None None None None NA
Olga Frankfurt MD None Celgene Corporation None None None
Lauren Gallagher None None None None None
Kristina Gregory MSN, RN, OCN None None None None NA
Robert Johnson MD, FACP None None None None NA
Joan McClure MS None None None None NA
Michael Millenson MD, FACP None None None None Johnson & Johnson
Arati Rao MD None Amgen Inc. Novartis Pharmaceuticals Corporation None None
Bijal Shah MD Agios, Inc.
AstraZeneca Pharmaceuticals LP
Incyte Corporation
Jazz Pharmaceuticals Inc.
Kite Pharma
Precision Biosciences
Adaptive Biotechnologies
Amgen Inc.
AstraZeneca Pharmaceuticals LP
BeiGene
Celgene Corporation
Kite Pharma
Novartis Pharmaceuticals Corporation
Pfizer Inc.
Precision Biosciences
Spectrum Pharmaceuticals, Inc.
None None NA
Andrei Shustov MD None None Celgene Corporation None NA
Sarika Trikha PharmD None None None None None
Geoffrey Uy MD AbbVie, Inc.
Agios, Inc.
Amgen Inc.
BioLineRx
Bristol-Myers Squibb Company
GlycoMimetics, Inc.
Jazz Pharmaceuticals Inc.
Macrogenics
AbbVie, Inc.
Agios, Inc.
GlaxoSmithKline
Novartis Pharmaceuticals Corporation
None None NA
Meir Wetzler MD Bristol-Myers Squibb Company
Cyclacel
MedPace
National Cancer Institute
OSU
Prime Oncology
Boehringer Ingelheim GmbH
Clinical Connexion
Dava
Envision
Intellsphere
McVeigh
MedLearning
P4 Healthcare
Sigma-Tao
WebMD
None None NA
Andrew Zelenetz MD, PhD BeiGene
Bristol-Myers Squibb Company
Celgene Corporation
Genentech, Inc.
Gilead Sciences, Inc.
Juno Therapeutics, Inc.
MEI Pharma Inc.
Roche Laboratories, Inc.
AbbVie, Inc.
Adaptive Biotech
Amgen Inc.
AstraZeneca Pharmaceuticals LP
Celgene Corporation
Genentech, Inc.
Gilead Sciences, Inc.
Janssen Pharmaceutica Products, LP
MEI Pharma Inc.
MorphoSys AG
Novartis Pharmaceuticals Corporation
None None NA